Global Journal of Medical Research, F: Diseases, Volume 23 Issue 2

R eferences R éférences R eferencias 1. Peres, LAB, et al. Biomarkers of acute kidney injury. Brazilian Journal of Nephrology, v. 35, no. 3, p. 229- 236, 2013-09 2013. ISSN 0101-2800. Available at: http://www.scielo.br/scielo.php?script=sci_arttext& pid=S0101-28002013000300010 https://doi.org/10.5935/0101-2800.20130036 2. Barroso et al. Brazilian Guidelines on Arterial Hypertension. Arch bras Cardiol. 2020; [online]. ahead print, PP.0-0 http:// DOI: 10.36660/abc. 20201238 3. State Department of Health of Paraná. Health Care Superintendence. Arterial hypertension guideline / SAS. – 2nd ed. – Curitiba: SESA, 2018. 52p. 4. Francisqueti FV, Nascimento AF, Correa CR. Obesity, inflammation and metabolic complications. Nourish. 2015 Apr; 40(1): 81-89. http://dx.doi.org/ 10.4322/2316-7874.016213 5. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2): 85-97. http://dx.doi.org/ 10.1038/nri2921. PMid:21252989 6. Trzeciak-Ryczek A, Tokarz-Deptuła B, Nied ź wiedzka-Rystwej P, Deptula W. Adipose tissue – component of the immune system. Center Eur J Immunol. 2011; 36: 95-9 http://doi: 10.1016/j.plefa. 2005.04.005. 7. Suganami T, Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol. 2010; 88(1): 33-9. http://dx.doi.org/10.1189/jlb.0210072. PMid:20360405 8. Oliveira FC, Alves MDS, Bezerra AP. Co-morbidities and mortality of patients with kidney disease: outsourced nephrology care. Acta Paul Enferm. 2009; 22 (Special–Nephrology): 476-80. https://doi. org/10.1590/S0103-21002009000800003. 9. Fujibayashi K, Fukuda H, Yokokawa H, Haniu T, Oka F, Ooike M, et al. Associations between healthy lifestyle behaviors and proteinuria and the estimated glomerular filtration rate (eGFR). J AtherosclerThromb 2012; 19: 932-40. http:// dx.doi.org/10.5551/jat.12781. 10. Kidney Disease: Improving Global Outcomes. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3:1-150. http://doi.org/10.1038/kisup.2012.73 11. Lotufo PA. The Framingham risk score for cardiovascular disease. Rev Med (São Paulo). 2008 Oct.-Dec.; 87(4): 232-7. https://doi.org/10.11606/ issn.1679-9836.v87i4p232-237 12. Update of the Brazilian Guideline for Dyslipidemia and Prevention of Atherosclerosis & Brazilian Guideline for the Prevention of Cardiovascular Disease in Patients with Diabetes, 2017. Cardiovascular Risk Stratification Calculator Available at: http://departamentos.cardiol.br/sbc-da/ 2015/CALCULATORAER2017/index.htmlhttps://doi. org/10.5935/abc.20170121 13. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta- analysis of prospective studies. Am J Kidney Dis [Internet]. 2011 [cited 2018 Jul 22]; 58(3):374-82. Available from: https://www.ajkd.org/article/S0272- 6386 ( 11) 00739-6/pdf https://doi.org/10.1053/ j.ajkd.2011.03.020 14. Levey AS, Stevens LA, Schmid CH, et al. for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med . 2009 May 5; 150:604-612. PubMed ID: 19414839 https://doi.org/10.7326/0003-4819-150-9-2009050 50-00006 15. IBGE, 2018. Available at: https://cidades.ibge.gov . br/brasil/ba/barreiras/panorama 16. Pontes FLI Junior, Prestes J, Leite RD, Rodriguez D. Influence of aerobic training on the pathophysiological mechanisms of systemic arterial hypertension. Rev bras Ciênc Sport. 2010; 32(2-4): 229-44. https://doi.org/10.1590/S0101-328920100 00200016 17. Brazil. Ministry of Health. Secretariat of Science, Technology, Innovation and Strategic Inputs in Health. Department of Management and Incorporation of Technologies and Innovation in Health. Clinical Protocol and Therapeutic Guidelines for Type 1 Diabetes Mellitus [electronicresource] – Brasília: Ministério da Saúde, 2020. 68 p. 18. Orth SR, Ritz E, Schrier RW. The renal risks of smoking. Kidney Int 1997; 51:1669-77. https://doi. org/10.1038/ki.1997.232 19. Stack AG, Murthy BV. Cigarette use and cardiovascular risk in chronic kidney disease: an unappreciated modifiable lifestyle risk factor. Semin Dial 2010; 23: 298-305. http://dx.doi.org/10.1111/ j.1525-139X.2010.00728. 20. Orth S, Stockmann A, Conradt C et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998; 54: 926-31. DOI: 10.1046/j.1523-1755.1998.00067.x 21. Bleyer A, Shemanski L, Burke G, Hansen K, Appel R. Tobacco, hypertension, and vascular disease: risk factors for renal function decline in an older population. Kidney Int 2000; 57:2072-9. DOI: 10.1046/j.1523-1755.2000.00056.x 22. Lotz M. Interleukin-6: a comprehensive review. In: Kurzrock R., Talpaz M., editors. Cytokines: Interleukins and their receptors. Springer; Boston, MA: 1995. pp. 209-233. DOI: 10.1007/978-1-4613- 1241-3_8 23. Sanchez JC; Lopez Z DF; Finch OA; et al. Adipokines and the metabolic syndrome: multiple 35 Year 2023 Global Journal of Medical Research Volume XXIII Issue II Version I ( D ) F © 2023 Global Journals Inflammatory Markers and Risk Factors in Hypertensive Patients: A Cross-Sectional Study